• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why KKR Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket

    6/10/24 5:59:44 AM ET
    $AIU
    $BCDA
    $CAPT
    $CLEU
    Other Consumer Services
    Real Estate
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AIU alert in real time by email

    Shares of KKR & Co. Inc. (NYSE:KKR) rose sharply in today's pre-market trading after it was announced the company will join the S&P 500.

    S&P Dow Jones Indices announced late Friday changes to various S&P indices, coinciding with the quarterly rebalance. KKR will take the place of Comerica Inc. (NYSE:CMA) in the broader gauge.

    KKR & Co. shares jumped 10.4% to $108.15 in the pre-market trading session.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Big Tree Cloud Holdings Limited (NASDAQ:DSY) rose 165% to $5.05 in today's pre-market trading.
    • New Horizon Aircraft Ltd. (NASDAQ:HOVR) gained 90.1% to $1.37 in pre-market trading after declining around 8% on Friday.
    • Spectaire Holdings Inc. (NASDAQ:SPEC) shares gained 59.3% to $0.6770 in pre-market trading after jumping over 15% on Friday.
    • Presto Automation Inc. (NASDAQ:PRST) shares rose 35.1% to $0.1204 in pre-market trading after surging 17% on Friday.
    • Meta Data Limited (NYSE:AIU) gained 34.5% to $0.5651 in pre-market trading after dipping 19% on Friday.
    • Nisun International Enterprise Development Group Co., Ltd (NASDAQ:NISN) shares rose 13.6% to $3.83 in pre-market trading after the company said it has established a daily supply capacity of over 20 million eggs.
    • Captivision Inc. (NASDAQ:CAPT) rose 13.5% to $3.40 in pre-market trading after declining around 12% on Friday.
    • Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) shares climbed 8.7% to $0.38 in pre-market trading after declining 5% on Friday.
    • Forward Air Corp (NASDAQ:FWRD) gained 7.1% to $22.13 in pre-market trading after gaining around 7% on Friday.

    Losers

    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) shares declined 33.7% to $0.37 in pre-market trading.
    • Roma Green Finance Limited (NASDAQ:ROMA) shares declined 18% to $0.4085 in pre-market trading. Roma Green Finance filed For offering in a best efforts self-underwritten offering of up to 3.6 million of ordinary shares.
    • Versus Systems Inc. (NASDAQ:VS) shares dipped 17.3% to $1.48 in pre-market trading after jumping over 8% on Friday.
    • China Liberal Education Holdings Limited (NASDAQ:CLEU) shares fell 16.8% to $2.66 in pre-market trading after jumping 58% on Friday.
    • Cumulus Media Inc (NASDAQ:CMLS) shares fell 15.2% to $2.01 in pre-market trading after jumping around 22% on Friday.
    • Venus Concept Inc. (NASDAQ:VERO) shares fell 15.1% to $0.7899 in pre-market trading after jumping 50% on Friday.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) shares fell 14.7% to $1.68 in pre-market trading.
    • Trinity Place Holdings Inc. (NYSE:TPHS) fell 14.5% to $0.15 in pre-market trading after jumping 45% on Friday.
    • Sify Technologies Limited (NASDAQ:SIFY) shares declined 10.7% to $0.7413 in pre-market trading after the company announced intent to delist ADS Rights from the Nasdaq Capital Market.
    • BioCardia, Inc. (NASDAQ:BCDA) shares fell 9.4% to $3.37 in pre-market trading. On Friday, BioCardia announced it received approval from the United States Patent Office for its application entitled, "Radial and Transendocardial Delivery Catheter."

    Now Read This: Investor Optimism Improves Slightly Following Jobs Data; US Stocks Record Weekly Gains

    Get the next $AIU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIU
    $BCDA
    $CAPT
    $CLEU

    CompanyDatePrice TargetRatingAnalyst
    KKR & Co. Inc.
    $KKR
    2/24/2026$137.00Outperform
    RBC Capital Mkts
    KKR & Co. Inc.
    $KKR
    1/28/2026$144.00Hold → Buy
    HSBC Securities
    KKR & Co. Inc.
    $KKR
    1/14/2026$131.00Buy → Hold
    TD Cowen
    KKR & Co. Inc.
    $KKR
    12/11/2025$176.00Buy
    UBS
    Comerica Incorporated
    $CMA
    10/30/2025$88.00Underperform → In-line
    Evercore ISI
    Comerica Incorporated
    $CMA
    10/10/2025$93.00Outperform → Mkt Perform
    Keefe Bruyette
    Comerica Incorporated
    $CMA
    10/7/2025$83.00Underweight → Equal-Weight
    Morgan Stanley
    Comerica Incorporated
    $CMA
    9/25/2025$75.00Hold
    TD Cowen
    More analyst ratings

    $AIU
    $BCDA
    $CAPT
    $CLEU
    SEC Filings

    View All

    BioCardia Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - BioCardia, Inc. (0000925741) (Filer)

    4/20/26 8:00:09 AM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Cumulus Media Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - CUMULUS MEDIA INC (0001058623) (Filer)

    4/17/26 4:15:32 PM ET
    $CMLS
    Broadcasting
    Consumer Discretionary

    Versus Systems Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Versus Systems Inc. (0001701963) (Filer)

    4/16/26 6:41:21 AM ET
    $VS
    EDP Services
    Technology

    $AIU
    $BCDA
    $CAPT
    $CLEU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Barakett Timothy R bought $4,723,500 worth of shares (50,000 units at $94.47) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    3/5/26 7:30:13 PM ET
    $KKR
    Investment Managers
    Finance

    Director Dillon Mary N bought $2,021,586 worth of shares (22,225 units at $90.96) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    3/3/26 4:34:01 PM ET
    $KKR
    Investment Managers
    Finance

    Co-Chief Executive Officer Bae Joseph Y bought $4,428,000 worth of shares (50,000 units at $88.56) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    3/3/26 4:34:04 PM ET
    $KKR
    Investment Managers
    Finance

    $AIU
    $BCDA
    $CAPT
    $CLEU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on KKR with a new price target

    RBC Capital Mkts initiated coverage of KKR with a rating of Outperform and set a new price target of $137.00

    2/24/26 7:55:00 AM ET
    $KKR
    Investment Managers
    Finance

    KKR upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded KKR from Hold to Buy and set a new price target of $144.00

    1/28/26 7:11:28 AM ET
    $KKR
    Investment Managers
    Finance

    KKR downgraded by TD Cowen with a new price target

    TD Cowen downgraded KKR from Buy to Hold and set a new price target of $131.00

    1/14/26 8:26:34 AM ET
    $KKR
    Investment Managers
    Finance

    $AIU
    $BCDA
    $CAPT
    $CLEU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Vertical Bridge Announces $1.5 billion Strategic Equity Investment from KKR

    Vertical Bridge REIT, LLC ("Vertical Bridge" or the "Company"), the largest private owner and operator of communications infrastructure in the United States, and leading global investment firm KKR today announced that KKR will make a $1.5 billion equity investment in the Company to support its future growth. The addition of KKR as a new investor establishes a fully funded, long‑term capital structure that supports Vertical Bridge's strategic plan and reinforces the Company's position as a permanent owner and operator of a nationwide portfolio of more than 17,000 towers. "This transaction provides us with the resources to continue developing our portfolio at scale while maintaining our d

    4/22/26 4:30:00 PM ET
    $DBRG
    $KKR
    Real Estate Investment Trusts
    Real Estate
    Investment Managers
    Finance

    HealthCare Royalty Announces Royalty Monetization Agreement for Modeyso® Commercial Royalties

    HealthCare Royalty ("HCRx") today announced it has entered into a royalty monetization agreement with the Advisory Group representing the former Oncoceutics Inc. securityholders for an undisclosed percentage of royalties on Modeyso® (dordaviprone) commercial sales. Modeyso received U.S. FDA accelerated approval in August 2025 for the treatment of adult and pediatric patients 1 year of age and older with diffuse midline glioma harboring an H3 K27M mutation with progressive disease following prior therapy. Modeyso is commercialized by Jazz Pharmaceuticals. "Since its launch in August, Modeyso has demonstrated strong early performance, reflecting the significant unmet need, high awareness

    4/22/26 3:26:00 PM ET
    $KKR
    Investment Managers
    Finance

    BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure

    SUNNYVALE, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (NASDAQ:BCDA), a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported a positive outcome in its formal clinical consultation with Japan's Pharmaceutical and Medical Device Agency (PMDA). PMDA has determined that the clinical safety and efficacy evidence for the CardiAMP® Cell Therapy in ischemic heart failure is likely sufficient to support market clearance. Good alignment was achieved in the meeting on the acceptability of the foreign clinical data that has been developed in the United States, the indications for use in patients, the approac

    4/20/26 8:00:00 AM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AIU
    $BCDA
    $CAPT
    $CLEU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Altman Peter

    4 - BioCardia, Inc. (0000925741) (Issuer)

    4/22/26 5:04:35 PM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Natan David

    4 - Sunshine Biopharma Inc. (0001402328) (Issuer)

    4/14/26 4:26:09 PM ET
    $SBFM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Lai Shan Shan

    3 - Roma Green Finance Ltd (0001945240) (Issuer)

    4/9/26 6:17:43 AM ET
    $ROMA
    Professional Services
    Consumer Discretionary

    $AIU
    $BCDA
    $CAPT
    $CLEU
    Leadership Updates

    Live Leadership Updates

    View All

    Sify reports Consolidated Financial Results for FY 2025-26

    Revenues of INR 44,877 Million. EBITDA of INR 9,871 Million. Loss for the year INR 1,366 Million. CHENNAI, India, April 13, 2026 (GLOBE NEWSWIRE) -- DETAILS OF EARNING CALL        April 13, 2026 | 8:30 AM ET | 06:00 PM IST Participant Dial in: To join: +1-888-506-0062 (Toll Free in the U.S. or Canada) or +1-973-528-0011 (International) | Access Code: 877273 On the call: Mr. Raju Vegesna, Chairman of the Board and Mr. M P Vijay Kumar, Executive Director & Group CFO Live webcast: https://www.webcaster5.com/Webcast/Page/2184/53862 Archives: +1-877-481-4010 (Toll Free in the U.S. or Canada) or +1-919-882-2331 (International). Passcode 53862 Replay is available until

    4/13/26 8:57:01 AM ET
    $SIFY
    Computer Software: Programming Data Processing
    Technology

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate

    KKR-led Consortium Drives Further Investment in Sylvan

    Global investment firm KKR today announced the completion of an additional investment in Sylvan, a world-leading fungal biotechnology company (the "Company"), through funds managed by KKR with participation from new investors and a follow-on investment from existing investor, Novo Holdings, which increased its ownership stake in the Company as part of this round. Following the investment, KKR remains the majority investor in Sylvan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120305013/en/ Founded in 1932, Sylvan is a world-leading mushroom spawn and fungal biotechnology company. The company seeks to harness the potential

    1/20/26 8:02:00 PM ET
    $KKR
    Investment Managers
    Finance

    $AIU
    $BCDA
    $CAPT
    $CLEU
    Financials

    Live finance-specific insights

    View All

    FSK Announces Earnings Release and Conference Call Schedule for First Quarter 2026

    PHILADELPHIA and NEW YORK, April 9, 2026 /PRNewswire/ -- FS KKR Capital Corp. (NYSE:FSK) announced today plans to release its first quarter 2026 results after the close of trading on the New York Stock Exchange on Wednesday, May 6, 2026. FSK will host its first quarter 2026 results conference call via live webcast on Thursday, May 7, 2026 at 9:00 a.m. (Eastern Time). All interested parties are welcome to participate and can access the live webcast from the For Investors section of FSK's website at www.fskkrcapitalcorp.com under Events & Presentations or through the following URL

    4/9/26 4:15:00 PM ET
    $FSK
    $KKR
    Investment Managers
    Finance

    Sify Technologies to announce Financial Results for FY 2025-26 on Monday, April 13, 2026

    CHENNAI, India, April 06, 2026 (GLOBE NEWSWIRE) -- Sify Technologies Limited (NASDAQ:SIFY), India's leading Digital ICT solutions provider with global service capabilities spanning Data Center, Cloud, Networks, Security and Digital services, today announced that it will report its unaudited IFRS financial results for the full year ended March 31, 2026 on Monday, April 13, 2026 before the market opens.  Following the announcement, Sify will host a conference call at 8:30 AM ET with Mr. Raju Vegesna, Chairman of the Board and Mr. M P Vijay Kumar, Executive Director & Group CFO. Interested parties may participate by dialling +1-888-506-0062 (Toll Free in the U.S. or Canada) or +1-973-528-001

    4/6/26 8:58:42 AM ET
    $SIFY
    Computer Software: Programming Data Processing
    Technology

    KKR & Co. Inc. to Announce First Quarter 2026 Results

    KKR & Co. Inc. (NYSE:KKR) announced today that it plans to release its financial results for the first quarter 2026 on Tuesday, May 5, 2026, before the opening of trading on the New York Stock Exchange. A conference call to discuss KKR's financial results will be held on Tuesday, May 5, 2026 at 10:00 a.m. ET. The conference call may be accessed by dialing (877) 407-0312 (U.S. callers) or +1 (201) 389-0899 (non-U.S. callers); a pass code is not required. Additionally, the conference call will be broadcast live over the Internet and may be accessed through the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. A replay of the live broadcast will be availab

    4/2/26 4:15:00 PM ET
    $KKR
    Investment Managers
    Finance

    $AIU
    $BCDA
    $CAPT
    $CLEU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Versus Systems Inc.

    SC 13G/A - Versus Systems Inc. (0001701963) (Subject)

    11/14/24 7:30:32 PM ET
    $VS
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Virax Biolabs Group Limited

    SC 13G/A - Virax Biolabs Group Ltd (0001885827) (Subject)

    11/14/24 4:46:07 PM ET
    $VRAX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13G/A filed by Sunshine Biopharma Inc.

    SC 13G/A - Sunshine Biopharma Inc. (0001402328) (Subject)

    11/14/24 4:28:14 PM ET
    $SBFM
    Biotechnology: Pharmaceutical Preparations
    Health Care